{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:16:18Z","timestamp":1764656178363,"version":"build-2065373602"},"reference-count":56,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004561","name":"Education and Science of the Republic of Kazakhstan","doi-asserted-by":"publisher","award":["AP09563474"],"award-info":[{"award-number":["AP09563474"]}],"id":[{"id":"10.13039\/501100004561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>The left ventricular assist device (LVAD) is one of the alternative treatments for heart failure (HF) patients. However, LVAD support is followed by thrombosis, and bleeding complications which are caused by high non-physiologic shear stress and antithrombotic\/anticoagulant therapy. A high risk of complications occurs in the presence of the genotype polymorphisms which are involved in the coagulation system, hemostasis function and in the metabolism of the therapy. The aim of the study was to investigate the influence of single-nucleotide polymorphisms (SNP) in HF patients with LVAD complications. We analyzed 21 SNPs in HF patients (n = 98) with\/without complications, and healthy controls (n = 95). SNPs rs9934438; rs9923231 in VKORC1, rs5918 in ITGB3 and rs2070959 in UGT1A6 demonstrated significant association with HF patients\u2019 complications (OR (95% CI): 3.96 (1.42\u201311.02), p = 0.0057), (OR (95% CI): 3.55 (1.28\u20139.86), p = 0.011), (OR (95% CI): 5.37 (1.79\u201316.16), p = 0.0056) and OR (95% CI): 4.40 (1.06\u201318.20), p = 0.044]. Genotype polymorphisms could help to predict complications at pre- and post-LVAD implantation period, which will reduce mortality rate. Our research showed that patients can receive treatment with warfarin and aspirin with a personalized dosage and LVAD complications can be predicted by reference to their genotype polymorphisms in VKORC1, ITGB3 and UGT1A6 genes.<\/jats:p>","DOI":"10.3390\/jpm12050744","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T08:21:25Z","timestamp":1651652485000},"page":"744","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of Genetic Polymorphisms with Complications of Implanted LVAD Devices in Patients with Congestive Heart Failure: A Kazakhstani Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-8913","authenticated-orcid":false,"given":"Madina R.","family":"Zhalbinova","sequence":"first","affiliation":[{"name":"National Laboratory Astana, Nazarbayev University, Nur-Sultan 010000, Kazakhstan"},{"name":"Department of General Biology and Genomics, L. N. Gumilyov Eurasian National University, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-2400","authenticated-orcid":false,"given":"Saule E.","family":"Rakhimova","sequence":"additional","affiliation":[{"name":"National Laboratory Astana, Nazarbayev University, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-7631","authenticated-orcid":false,"given":"Ulan A.","family":"Kozhamkulov","sequence":"additional","affiliation":[{"name":"National Laboratory Astana, Nazarbayev University, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulbanu A.","family":"Akilzhanova","sequence":"additional","affiliation":[{"name":"Semey Medical University, Pavlodar Branch, Pavlodar 140000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina K.","family":"Kaussova","sequence":"additional","affiliation":[{"name":"Kazakhstan Medical University \u201cKSPH\u201d, Almaty 050000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenes R.","family":"Akilzhanov","sequence":"additional","affiliation":[{"name":"Semey Medical University, Pavlodar Branch, Pavlodar 140000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriy V.","family":"Pya","sequence":"additional","affiliation":[{"name":"National Research Cardiac Surgery Center, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-4821","authenticated-orcid":false,"given":"Joseph H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Sergievsky Center, Taub Institute, Columbia University Irving Medical Centerx, 630 W, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-617X","authenticated-orcid":false,"given":"Makhabbat S.","family":"Bekbossynova","sequence":"additional","affiliation":[{"name":"National Research Cardiac Surgery Center, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-8355","authenticated-orcid":false,"given":"Ainur R.","family":"Akilzhanova","sequence":"additional","affiliation":[{"name":"National Laboratory Astana, Nazarbayev University, Nur-Sultan 010000, Kazakhstan"},{"name":"Department of General Biology and Genomics, L. N. Gumilyov Eurasian National University, Nur-Sultan 010000, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-018-2483-8","article-title":"Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD)","volume":"74","author":"Nakagita","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11748-016-0671-y","article-title":"Current status of the implantable LVAD","volume":"64","author":"Kadakia","year":"2016","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"ref_4","first-page":"573","article-title":"Comparison of continuous-flow and pulsatile-flow left ventricular assist devices: Is there an advantage to pulsatility?","volume":"3","author":"Cheng","year":"2014","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ehf2.12066","article-title":"Initial 3-year outcomes with left ventricular assist devices in a country with a nascent heart transplantation program","volume":"3","author":"Pya","year":"2016","journal-title":"ESC Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ejcts\/ezw169","article-title":"Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes","volume":"50","author":"Zimpfer","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/09537104.2014.948840","article-title":"Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device","volume":"26","author":"Mondal","year":"2015","journal-title":"Platelets"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/jth.13120","article-title":"Circulatory support devices: Fundamental aspects and clinical management of bleeding and thrombosis","volume":"13","author":"Susen","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MAT.0000000000000390","article-title":"Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices","volume":"62","author":"Topkara","year":"2016","journal-title":"ASAIO J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/eurheartj\/ehaa639","article-title":"Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: Results from the ELEVATE Registry","volume":"41","author":"Zimpfer","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MAT.0000000000000231","article-title":"Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support","volume":"61","author":"Awad","year":"2015","journal-title":"ASAIO J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MAT.0000000000000592","article-title":"Anticoagulation Control in Patients with Ventricular Assist Devices","volume":"63","author":"Boehme","year":"2017","journal-title":"ASAIO J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(13)60681-9","article-title":"Genetic variants associated with warfarin dose in African-American individuals: A genome-wide association study","volume":"382","author":"Perera","year":"2013","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/pgs.10.49","article-title":"Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups","volume":"11","author":"Scott","year":"2010","journal-title":"Pharmacogenomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2217\/14622416.9.10.1445","article-title":"VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African\u2013Americans and European\u2013Americans","volume":"9","author":"Limdi","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11010-015-2515-y","article-title":"Activation and shedding of platelet glycoprotein IIb\/IIIa under non-physiological shear stress","volume":"409","author":"Chen","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MAT.0000000000000722","article-title":"Quantitative Characterization of Shear-Induced Platelet Receptor Shedding: Glycoprotein Ibalpha, Glycoprotein VI, and Glycoprotein IIb\/IIIa","volume":"64","author":"Chen","year":"2018","journal-title":"ASAIO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ahj.2007.05.021","article-title":"Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction","volume":"154","author":"Knowles","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2008.01105.x","article-title":"The genetics of antiplatelet drug resistance","volume":"75","author":"Feher","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.2174\/138161212803251907","article-title":"Pharmacogenetics of the Antiplatelet Effect of Aspirin","volume":"18","author":"Wurtz","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40291-016-0190-7","article-title":"Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals","volume":"20","author":"Alrashid","year":"2016","journal-title":"Mol. Diagn Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1592\/phco.28.9.1084","article-title":"Warfarin pharmacogenetics","volume":"28","author":"Limdi","year":"2008","journal-title":"Pharmacotherapy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00228-013-1581-x","article-title":"Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population","volume":"70","author":"Shewade","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/138920009790711814","article-title":"Pharmacogenomics in Aspirin Intolerance","volume":"10","author":"Carballo","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-006-0260-8","article-title":"Association of warfarin dose with genes involved in its action and metabolism","volume":"121","author":"Wadelius","year":"2007","journal-title":"Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1538-7836.2008.02920.x","article-title":"Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis","volume":"6","author":"Baglin","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shi, H., Yang, S., Liu, Y., Huang, P., Lin, N., Sun, X., Yu, R., Zhang, Y., Qin, Y., and Wang, L. (2015). Study on Environmental Causes and SNPs of MTHFR, MS and CBS Genes Related to Congenital Heart Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128646"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1086\/321276","article-title":"Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer","volume":"69","author":"Ritchie","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0381-4-24","article-title":"An R package implementation of multifactor dimensionality reduction","volume":"4","author":"Winham","year":"2011","journal-title":"BioData Min."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Patron, J., Serra-Cayuela, A., Han, B., Li, C., and Wishart, D.S. (2019). Assessing the performance of genome-wide association studies for predicting disease risk. PLoS ONE, 14.","DOI":"10.1101\/701086"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jsps.2019.01.011","article-title":"Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy","volume":"27","author":"Almasri","year":"2019","journal-title":"Saudi Pharm. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.healun.2015.01.022","article-title":"Association of Warfarin Genotype with Thrombosis and Bleeding Events in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients","volume":"34","author":"Topkara","year":"2015","journal-title":"J. Heart Lung Transpl."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.healun.2013.08.013","article-title":"Platelet glycoprotein Ibalpha ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices","volume":"33","author":"Hu","year":"2014","journal-title":"J. Heart Lung Transpl."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/aor.13445","article-title":"Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding","volume":"43","author":"Chen","year":"2019","journal-title":"Artif. Organs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/HCO.0000000000000284","article-title":"Bleeding and thrombosis in chronic ventricular assist device therapy: Focus on platelets","volume":"31","author":"Koliopoulou","year":"2016","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/gtmb.2017.0177","article-title":"The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting","volume":"22","author":"Grinshtein","year":"2018","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/10408361003791520","article-title":"Genetic aspects of ischemic stroke: Coagulation, homocysteine, and lipoprotein metabolism as potential risk factors","volume":"47","author":"Stankovic","year":"2010","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.atherosclerosis.2011.01.038","article-title":"Association of the platelet GPIIb\/IIIa polymorphism with atherosclerotic plaque morphology: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"216","author":"Monda","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2796.2004.01327.x","article-title":"The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction","volume":"255","author":"Grove","year":"2004","journal-title":"J. Int. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.thromres.2005.01.008","article-title":"Detection of the Leu40Arg variant of the platelet glycoprotein IIb\/IIIa receptor in subjects with thrombotic diseases","volume":"116","author":"Nadasi","year":"2005","journal-title":"Thromb. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/HJH.0b013e328013cd67","article-title":"The PlA1\/A2 polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: Increased risk of ischemic stroke in high-risk patients","volume":"25","author":"Lanni","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2125.2005.02495.x","article-title":"Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid","volume":"60","author":"Huybers","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200053586064","article-title":"Polymorphism of UDP-Glucuronosyltransferase and Drug Metabolism","volume":"6","author":"Maruo","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.fpc.0000236339.79916.07","article-title":"UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin","volume":"17","author":"Chen","year":"2007","journal-title":"Pharmacogen. Genom."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sheth, H., Northwood, E., Ulrich, C.M., Scherer, D., Elliott, F., Barrett, J.H., Forman, D., Wolf, C.R., Smith, G., and Jackson, M.S. (2018). Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192223"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0300060517730174","article-title":"Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/gcc.22167","article-title":"Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry","volume":"53","author":"Scherer","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3748\/wjg.15.2240","article-title":"No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk","volume":"15","author":"Thompson","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Iskakova, A.N., Romanova, A.A., Aitkulova, A.M., Sikhayeva, N.S., Zholdybayeva, E.V., and Ramanculov, E.M. (2016). Polymorphisms in genes involved in the absorption, distribution, metabolism, and excretion of drugs in the Kazakhs of Kazakhstan. BMC Genet., 17.","DOI":"10.1186\/s12863-016-0329-x"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2013.08.1656","article-title":"Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: An analysis of more than 900 HeartMate II outpatients","volume":"63","author":"Boyle","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5675084","DOI":"10.1155\/2016\/5675084","article-title":"Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet Function","volume":"2016","author":"Xiang","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sciaccaluga, C., Ghionzoli, N., Mandoli, G.E., D\u2019Ascenzi, F., Focardi, M., Valente, S., and Cameli, M. (2022). Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence. Biomolecules, 12.","DOI":"10.3390\/biom12020334"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e925","DOI":"10.1097\/MD.0000000000000925","article-title":"Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article","volume":"94","author":"Oussalah","year":"2015","journal-title":"Medicine"},{"key":"ref_54","first-page":"351","article-title":"Association between uridin diphosphate glucuronosylotransferase 1A1 (UGT1A1) gene polymorphism and neonatal hyperbilirubinemia","volume":"64","author":"Romanowski","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/bmm.12.4","article-title":"Gilbert syndrome: The UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism","volume":"6","year":"2012","journal-title":"Biomark. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sarajlic, P., Simonsson, M., Jernberg, T., Back, M., and Hofmann, R. (2021). Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: A SWEDEHEART-based nationwide cohort study. Eur. Heart J. Cardiovasc. Pharmacother., 1\u20139.","DOI":"10.1093\/ehjcvp\/pvab059"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/5\/744\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:05:52Z","timestamp":1760137552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/5\/744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["jpm12050744"],"URL":"https:\/\/doi.org\/10.3390\/jpm12050744","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2022,5,4]]}}}